Vaccination of children could lead far towards getting students back into the classroom this fall.
Pfizer said Wednesday that its Covid-19 vaccine was 100% effective in a study of 12- to 15-year-olds.
And yet, Keri Rodrigues, founder and founder and chairman of the National Parents Association, an education advocacy group, said the drug manufacturer’s announcement could provide some supervisors with a new excuse to delay personal learning this spring.
More Personal Finance:
Research: The virtual school led to “significant” learning difficulties
Many schools have difficulty reopening for personal learning
Biden plans to reopen schools
“We think this is great news, but it should not be used as another goal post that we need to fill out before schools can open,” he said.
Centers for Disease Control and Prevention have already updated their guidelines on how to safely reopen schools for personal learning despite the spread of the coronavirus.
The CDC now says that most students can sit at a distance of 3 meters instead of 6 feet as long as they wear masks, regardless of whether the community broadcast is low, moderate, or significant. Vaccination is not required.
“Vaccination of children is also complicated for many parents who fear the long-term effects of these vaccines,” Rodrigues added.
“It’s one thing to vaccinate adults- but we should do everything we can to give parents confidence that these vaccines are safe in the short and long term.”
The Pfizer-BioNTech vaccine is already approved for use in the United States by people 16 years of age and older.
Order CNBC on YouTube.